unknown node
unknown node
unknown node
unknown node
unknown node
unknown node
- unknown node
- unknown node
- unknown node
- unknown node
unknown node
unknown node
unknown node
unknown node
Hospital-acquired Infections · Case-Based Insights · Quality Control · Lab Operations
Case study: closing an MRSA screening gap in a surgical unit
Key takeaways
Late MRSA screening is usually a workflow diagnosis, not an assay problem: transport cadence, batching, and result-release gates determine whether a fast assay delivers fast decisions. Measure collection-to-isolation time and pre-isolated positives to verify any fix.
- Diagnose transport, batching, and release gates before replacing the assay.
- Route high-risk admissions through a rapid pathway; keep routine screens batched.
- Run confirmatory culture in parallel for epidemiology — not as a gate on isolation.
- Track collection-to-isolation interval and the share of positives isolated at release.
Target audienceInfection Prevention, Lab Director, Operations
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-06
2026-10-06
professional use
References
FAQ
Common questions
Is this a real hospital’s data?
No. This is a composite scenario assembled from common, well-described failure patterns in screening workflows. It is illustrative and does not describe a specific institution.
Why not simply isolate every admission?
Universal isolation consumes isolation rooms, staffing, and patient experience. Screening aims to target precautions where they matter; if screening results arrive late, the targeting logic fails regardless of assay quality.
Does a molecular positive need culture confirmation before isolation?
In the workflow pattern described, no: a validated molecular result triggers isolation, while culture runs in parallel for epidemiology and susceptibility data. Local policy and accreditation requirements always govern.
What single metric best reflects a screening programme?
Median time from screening collection to isolation decision, paired with the proportion of positive patients already isolated when the result releases. Both move only when the whole workflow works.